Nasal Powder Formulation of Tranexamic Acid and Hyaluronic Acid for the Treatment of Epistaxis-Reference-Cited by-同舟云学术

Nasal Powder Formulation of Tranexamic Acid and Hyaluronic Acid for the Treatment of Epistaxis

Published:2020-09-04 Issue:10 Volume:37 Page:
ISSN:0724-8741
Container-title:Pharmaceutical Research
language:en
Short-container-title:Pharm Res

Author:

Gomes dos Reis Larissa,Ghadiri Maliheh,Young Paul,Traini Daniela^ORCID

Funder

Woolcock Institute of Medical Research

Publisher

Springer Science and Business Media LLC

Subject

Pharmacology (medical),Organic Chemistry,Pharmaceutical Science,Pharmacology,Molecular Medicine,Biotechnology

Link

https://link.springer.com/content/pdf/10.1007/s11095-020-02913-w.pdf

Reference39 articles.

1. Smith J, Hanson J, Chowdhury R, Bungard TJ. Community-based management of epistaxis: Who bloody knows? Canadian pharmacists journal : CPJ = Revue des pharmaciens du Canada. RPC. 2019;152(3):164–76.

2. Kamhieh Y, Fox H. Tranexamic acid in epistaxis: a systematic review. Clin Otolaryngol: Off J ENT-UK; Off J Netherlands Soc Oto-Rhino-Laryngology Cervico-Facial Surg. 2016;41(6):771–6.

3. Rajapaksa SP, Cowin A, Adams D, Wormald PJ. The effect of a hyaluronic acid-based nasal pack on mucosal healing in a sheep model of sinusitis. Am J Rhinol. 2005;19(6):572–6.

4. Penrose N, May G. Tranexamic acid in epistaxis: who bloody nose? Emerg Med J. 2016;33(11):823–5.

5. Organization WH. Updated WHO recommendation on tranexamic acid for the treatment of postpartum haemorrhage: highlights and key messages from the World Health Organization's 2017 global recommendation. 2017. Contract No.: WHO/RHR/17.21.

Cited by 11 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Prolonged joint cavity retention of tranexamic acid achieved by a solid-in-oil-in-gel system: A preliminary study;International Journal of Pharmaceutics;2024-07

2. A Cell-Based Nasal Model for Screening the Deposition, Biocompatibility, and Transport of Aerosolized PLGA Nanoparticles;Molecular Pharmaceutics;2024-02-09

3. Amorphous nasal powder advanced performance: in vitro/ex vivo studies and correlation with in vivo pharmacokinetics;Journal of Pharmaceutical Investigation;2023-09

4. Salts of S-(+)-Ibuprofen Formed via Its Reaction with the Antifibrinolytic Agents Aminocaproic Acid and Tranexamic Acid: Synthesis and Characterization;Crystals;2023-08-08

5. Polysaccharide-based platforms for nasal delivery: design, features, and perspectives;Journal of Pharmaceutical Investigation;2023-06-30